Rockford Center

rockfordcenter.com

Rockford Center is a 138-bed mental health facility located in Newark, DE, providing easy access to a full complement of inpatient and partial behavioral health programs for children and adolescents, adults, and older adults. The mission of Rockford Center is to serve the needs of our regions mental health consumers by offering all of our patients and families outstanding healthcare services that are consistently trauma responsive, empowering and respectful, and which promote and sustain recovery. This critical mission is accomplished by working in partnership with individuals, families, healthcare providers, and other community stakeholders.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

JUBILANT RADIOPHARMA AND SOFIE BIOSCIENCES INK STRATEGIC COLLABORATION AGREEMENT TO FURTHER ADVANCE THE FIELD OF MOLECULAR IMAGING & THERAPEUTICS

SOFIE Biosciences, Inc. | November 05, 2020

news image

SOFIE Biosciences, Inc. ("SOFIE"), an established radiopharmaceutical supplier and worldwide radiopharmaceutical contract manufacturing organization, and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, announced that both the organizations have entered into a strategic partnership. Under the terms of the partnership, Jubilant Pharma, via one of its wholly owned subsidiaries, with 25% of equity holding shall be a strategic partner to SOFIE, enabling SOFIE to contin...

Read More

PHARMACY MARKET

BIOMAP ESTABLISHES A STRATEGIC COLLABORATION WITH SANOFI TO CO-DEVELOP AI MODULES TO ACCELERATE DRUG DISCOVERY FOR BIOTHERAPEUTICS

Business Wire | October 17, 2023

news image

BioMap announced a groundbreaking strategic collaboration with Sanofi to co-develop cutting-edge AI modules for biotherapeutic drug discovery leveraging BioMap’s AI platform. “As the largest foundational model-based approach within life sciences, we are thrilled to collaborate with Sanofi and leverage the potential of BioMap’s cutting-edge AI engine to help solve compl...

Read More

Business Insights

MRM PROTEOMICS, INC. AND AGILENT TECHNOLOGIES, INC.: A COLLABORATION FOR PROGRESS

MRM Proteomics, Inc. | February 04, 2022

news image

MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced expertise and state-of-the-art mass spectrometry technology, along with ...

Read More

Business Insights, PHARMA TECH

MTTI RECEIVES CHINESE PATENT FOR EVATHERA TECHNOLOGY

Molecular Targeting Technologies, Inc. | December 07, 2022

news image

Molecular Targeting Technologies, Inc. announces the issuance of Chinese Patent CN109153641B covering MTTI’s lead radiotherapeutic product, EBTATE™ and others in its EvaThera™ platform. Approval of “Chemical conjugates of Evans blue derivatives and their use as radiotherapeutic and imaging agents” follows issued patents in the US, Europe, Singapore, and Japan this past year. EBTATE is a new generation of peptide receptor radiotherapeutic drug that has...

Read More
news image

JUBILANT RADIOPHARMA AND SOFIE BIOSCIENCES INK STRATEGIC COLLABORATION AGREEMENT TO FURTHER ADVANCE THE FIELD OF MOLECULAR IMAGING & THERAPEUTICS

SOFIE Biosciences, Inc. | November 05, 2020

SOFIE Biosciences, Inc. ("SOFIE"), an established radiopharmaceutical supplier and worldwide radiopharmaceutical contract manufacturing organization, and Jubilant Radiopharma, a business division of Jubilant Pharma Limited, announced that both the organizations have entered into a strategic partnership. Under the terms of the partnership, Jubilant Pharma, via one of its wholly owned subsidiaries, with 25% of equity holding shall be a strategic partner to SOFIE, enabling SOFIE to contin...

Read More
news image

PHARMACY MARKET

BIOMAP ESTABLISHES A STRATEGIC COLLABORATION WITH SANOFI TO CO-DEVELOP AI MODULES TO ACCELERATE DRUG DISCOVERY FOR BIOTHERAPEUTICS

Business Wire | October 17, 2023

BioMap announced a groundbreaking strategic collaboration with Sanofi to co-develop cutting-edge AI modules for biotherapeutic drug discovery leveraging BioMap’s AI platform. “As the largest foundational model-based approach within life sciences, we are thrilled to collaborate with Sanofi and leverage the potential of BioMap’s cutting-edge AI engine to help solve compl...

Read More
news image

Business Insights

MRM PROTEOMICS, INC. AND AGILENT TECHNOLOGIES, INC.: A COLLABORATION FOR PROGRESS

MRM Proteomics, Inc. | February 04, 2022

MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced expertise and state-of-the-art mass spectrometry technology, along with ...

Read More
news image

Business Insights, PHARMA TECH

MTTI RECEIVES CHINESE PATENT FOR EVATHERA TECHNOLOGY

Molecular Targeting Technologies, Inc. | December 07, 2022

Molecular Targeting Technologies, Inc. announces the issuance of Chinese Patent CN109153641B covering MTTI’s lead radiotherapeutic product, EBTATE™ and others in its EvaThera™ platform. Approval of “Chemical conjugates of Evans blue derivatives and their use as radiotherapeutic and imaging agents” follows issued patents in the US, Europe, Singapore, and Japan this past year. EBTATE is a new generation of peptide receptor radiotherapeutic drug that has...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us